: Lipin-1 silencing inhibits PC-3 cells proliferation as determined by cell counting. Immediately after transfection with a control siRNA (Scr) or with a siRNA targeting lipin-1 (siLipin1(1) or siLipin1(2)) cells were seeded in 12-well plates and collected at the indicated times after trypsin-EDTA treatment. The number of cells in each well was measured as described in "Materials and Methods". ***: p< 0.001 as determined by ANOVA followed by Tukey-Kramer analysis. Supplemental Fig.8 . The inhibition of migration mediated by lipin-1 silencing is not altered following co-silencing lipin-2. Immediately after transfection with 20 nM of a control siRNA, 20 nM of the first siRNA targeting lipin-1 (siLipin1) or 20 nM of the first siRNA targeting lipin-1+20 nM of an siRNA targeting lipin-2 (siLipin1+siLipin2) cells were processed for the wound healing assay as described in "Materials and Methods". Representative phase contrast microscopy photographs were taken immediately after releasing the insert (0h) and 16 hours later (16h). Bar = 250 µm. N.S.: not significant ***p<0.001 ANOVA followed by Tukey-Kramer analysis. The graphs summarize the results of three independent experiments.
Supplemental Fig. 9 . Potentiation of the anti-proliferative effect of rapamycin by pharmacological inhibition of lipin-1 as determined by direct cell counting. PC-3 cells seeded in 12-well plates were treated with 50 nM rapamycin (rapa) and/or 100 µM propranolol (propr). The number of cells in each well was measured as described in "Materials and Methods". *** p< 0.001 ANOVA followed by Tukey-Kramer analysis.
